11TH INTERAMERICAN ONCOLOGY CONFERENCE
HYBRID CONFERENCE ‟CURRENT STATUS AND FUTURE OF ANTI-CANCER THERAPIES” VIRTUAL & LIVE IN- PERSON CONFERENCE
JULY 17-18, 2025
- 00
Days
- 00
Hours
- 00
Minutes
- 00
Seconds
VIRTUAL & LIVE IN- PERSON CONFERENCE
Venue: Universidad Católica Argentina
San José Building – Juan Pablo II Meeting Room
Av. Alicia M. de Justo 1680, Puerto Madero
Buenos Aires, Argentina
The hybrid format will include a two day live program, which will be a combination of on-site and online presentations. The interactive virtual format will be available for those who may choose to participate from a distance. So you can attend the IAOC conference either on-site in Buenos Aires or virtually.
An outstanding faculty of speakers from the United States and Europe has committed to participate in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types.
FACULTY
Alex A. Adjei, MD, PH.D, FACP
Cleveland Clinic , USA
Chairman Taussig Cancer Institute - Cleveland Clinic - Cleveland, Ohio, USA
Stephen M. Ansell, MD, Ph.D
Mayo Clinic Cancer Center, USA
CHAIR LYMPHOMA GROUP - MAYO CLINIC- ROCHESTER, MINNESOTA, USA
Carlos H. Barrios, MD
Hospital São Lucas, PUCRS , Brazil
Grupo Oncoclínicas de Pesquisa em Oncologia, Hospital São Lucas, PUCRS - Latin American Cooperative Oncology Group (LACOG) - Porto Alegre RS, Brazil
Joaquim Bellmunt, MD, Ph.D
Dana-Farber Cancer Institute , USA
Associate Professor, Medicine - Harvard Medical School - Director Bladder Cancer Center - Dana-Farber Cancer Institute - Boston, Massachusetts, USA
Enriqueta Felip, MD, Ph.D
Vall d’Hebron Institute of Oncology , Spain
Section in Chief, Medical Oncology Department - Vall d’Hebron University Hospital - Head, Thoracic Oncology and H&N Cancer Unit - Vall d’Hebron Institute of Oncology (VHIO) - Professor of Medicine, UVic-UCC - Vall d’Hebron Institute of Oncology - Barcelona, Spain
GUILLERMO GARCIA-MANERO, MD
MD Anderson Cancer Center, USA
CHIEF, SECTION OF MDS- MD ANDERSON CANCER CENTER- HOUSTON, TEXAS, USA.
IRENE GHOBRIAL, MD
DANA-FARBER CANCER INSTITUTE, USA
SENIOR VICE PRESIDENT FOR EXPERIMENTAL MEDICINE- DANA-FARBER CANCER INSTITUTE- BOSTON, USA
NATASHA LEIGHL, MD, MMSC, FRCPC, FASCO
PRINCESS MARGARET CANCER CENTRE, CANADA.
OSI PHARMACEUTICALS FOUNDATION CHAIR - PRINCESS MARGARET CANCER CENTRE- TORONTO, CANADA
CLARA MONTAGUT, MD, PH.D
HOSPITAL DEL MAR RESEARCH INSTITUTE, SPAIN
HEAD, GASTROINTESTINAL CANCER UNIT- HOSPITAL DEL MAR RESEARCH INSTITUTE-BARCELONA, SPAIN
Ana Oaknin, MD, PH.D
Vall d´Hebron Institute of Oncology, Spain
Head of Gynecological Cancer Program - Medical Oncology Department - Vall d´Hebron University Hospital - Vall d´Hebron Institute of Oncology( VHIO) - Barcelona, Spain
BEGOÑA PEREZ VALDERRAMA, MD
UNIVERSITY HOSPITAL VIRGEN DEL ROCÍO, SPAIN
GENITOURINARY AND GYNECOLOGICAL TUMORS UNIT- UNIVERSITY HOSPITAL VIRGEN DEL ROCÍO- SEVILLE, SPAIN
Antoni Ribas, MD, Ph.D
Jonsson Comprehensive Cancer Center , USA
Professor of Medicine and Surgery - Professor of Molecular and Medical Pharmacology - Director Tumor Immunology Program, Jonsson - Comprehensive Cancer Center (JCCC) - David Geffen School of Medicine, UCLA - Los Angeles, California, USA
Christian Rolfo, MD, PH.D, MBA, Dr.hc
ARTHUR G. JAMES CANCER HOSPITAL, Ohio, USA
DIRECTOR, DIVISION OF MEDICAL ONCOLOGY- ASSOCIATE DIRECTOR FOR EARLY PHASE CLINICAL TRIALS - A.G. JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE- OHIO, USA
HARRY YOON, MD, MHS
MAYO CLINIC COMPREHENSIVE CANCER CENTER, USA
ENTERPRISE VICE-CHAIR, GASTROINTESTINAL CANCER DISEASE GROUP- MAYO CLINIC COMPREHENSIVE CANCER CENTER - ROCHESTER, MINNESOTA, USA
ENDORSED BY
AAOC
(Asociación Argentina de Oncología Clínica)
ACHO
(Asociación Colombiana de Hematología y Oncología)
INC
(Instituto Nacional del Cáncer)
LACOG
(Latin American Cooperative Oncology Group)
SAU
(Sociedad Argentina de Urología)
SBOC
(Sociedade Brasileira de Oncologia Clínica)
SCOM
(Sociedad Chilena de Oncología Médica)
SOMPU
(Sociedad de Oncología Médica y Pediátrica del Uruguay)
SPOM
(Sociedad Peruana de Oncología Médica)
RECOMMENDED BY:
ESO
(European School of Oncology)
MEETING OF INTEREST BY:
CONICET
(Consejo Nacional de Investigaciones Científicas y Técnicas)
MEETING OF INTEREST BY:
EORTC
(European Organisation for Research an Treatment of Cancer)
OUR SPONSORS
The Organizing Committee would like to thank the following sponsors
PREVIOUS CONFERENCES
10th INTERAMERICAN ONCOLOGY CONFERENCE
6-7 July, 2023
9th INTERAMERICAN ONCOLOGY CONFERENCE
9-10 July, 2021
8th INTERAMERICAN ONCOLOGY CONFERENCE
7-18 October, 2019
7th INTERAMERICAN ONCOLOGY CONFERENCE
5-6 October, 2017
6th INTERAMERICAN ONCOLOGY CONFERENCE
8-9 October, 2015
5th INTERAMERICAN ONCOLOGY CONFERENCE
10-11 October, 2013
4th INTERAMERICAN ONCOLOGY CONFERENCE
6-7 October, 2011
3rd INTERAMERICAN ONCOLOGY CONFERENCE
1-2 October, 2009
2nd INTERAMERICAN ONCOLOGY CONFERENCE
13-14 September, 2007
